NLTX News and Press, Neoleukin Therapeutics Inc.

2023-12-15 04:18:07 ET More on Neoleukin Therapeutics Financial information for Neoleukin Therapeutics For further details see: Neoleukin Therapeutics announces 1-for-4 reverse stock split

SEATTLE, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” or the “Company” (NASDAQ:NLTX), a biopharmaceutical company that has designed de novo protein therapeutics utilizing sophisticated computational methods, today announced that its B...

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

Neoleukin Therapeutics Inc. (NLTX) is expected to report $-0.8 for Q3 2023

2023-09-22 13:13:32 ET More on Neoleukin Therapeutics Seeking Alpha’s Quant Rating on Neoleukin Therapeutics Historical earnings data for Neoleukin Therapeutics Financial information for Neoleukin Therapeutics For further details see: Neoleukin The...

SEATTLE, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” or the “Company” (NASDAQ:NLTX), a biopharmaceutical company that has designed de novo protein therapeutics utilizing sophisticated computational methods, today announced that its ...

2023-08-31 03:30:52 ET Summary Baker Brothers' 13F portfolio value decreased from $18.38B to $17.28B. The largest five stakes in the portfolio are Seagen, Incyte, BeiGene, ACADIA Pharmaceuticals, and Madrigal Pharmaceuticals, making up around 83% of the portfolio. Baker Brothe...

NEW YORK, NY / ACCESSWIRE / August 3, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Pardes Biosciences, Inc. (NASDAQ:PRD...

NEW YORK, NY / ACCESSWIRE / July 26, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Sculptor Capital Management Inc. (NYS...

NEW YORK, NY / ACCESSWIRE / July 23, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Denbury Inc. (NYSE: DEN)'s sale to ...